KAS
NVCR icon

Kestra Advisory Services’s NovoCure NVCR Stock Holding History

Kestra Advisory Services’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,763
Closed -$48.7K – 3984
2025
Q4 		$48.7K Buy
+3,763
New +$48.3K ﹤0.01% 3958
2021
Q4 		– Sell
-1,908
Closed -$222K – 2138
2021
Q3 		$222K Buy
1,908
+150
+9% +$22.7K ﹤0.01% 1909
2021
Q2 		$390K Sell
1,758
-802
-31% -$156K ﹤0.01% 1414
2021
Q1 		$338K Sell
2,560
-401
-14% -$63.4K ﹤0.01% 1388
2020
Q4 		$516K Buy
2,961
+2,926
+8,360% +$400K 0.01% 1191
2020
Q3 		$290K Buy
+35
New +$2.8K 0.01% 1135

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Kestra Advisory Services's NVCR Position: Q1 2026 in Review

Kestra Advisory Services sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 3,763 shares — an estimated $48.7K sold.

Kestra Advisory Services first reported a position in NVCR in Q3 2020 and held it in 6 quarters. The position peaked at $516K in Q4 2020. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Kestra Advisory Services reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 3,763 NovoCure shares in Q1 2026, an estimated $48.7K.
  • Kestra Advisory Services first reported a position in NovoCure in Q3 2020 and held it in 6 quarters.
  • Kestra Advisory Services's NovoCure position peaked at $516K in Q4 2020.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.